F. Ostronic

Direktor/Vorstandsmitglied bei CYCLO THERAPEUTICS, INC.

Vermögen: 446 427 $ am 31.05.2024

68 Jahre

Consumer Services

Health Technology

Aktive Positionen von F. Ostronic

Unternehmen	Position	Beginn	Ende
CYCLO THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	09.04.2014	-
CYCLO THERAPEUTICS, INC.	Independent Dir/Board Member	09.04.2014	-
The Usp Group, Inc.	Finanzdirektor/CFO	-	-
Novit US, Inc.	Direktor/Vorstandsmitglied	-	-
Novit LP	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
Tamir Biotechnology, Inc. Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ.	Direktor/Vorstandsmitglied	05.02.2013	-

College of the Holy Cross (Massachusetts)	Undergraduate Degree
Old Dominion University	Graduate Degree
The University of Maryland Francis King Carey School of Law	Graduate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	3
Graduate Degree	2
Independent Dir/Board Member	1

Sektoral

Consumer Services	4
Health Technology	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
CYCLO THERAPEUTICS, INC.	Health Technology

Private Unternehmen	4
Tamir Biotechnology, Inc. Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ.	Health Technology
The Usp Group, Inc.
Novit US, Inc.
Novit LP